"Reforming Healthcare by preventing diseases through next generation vaccines”.
“......Prior to BMI’s discovery, identifying new monoclonal antibodies is currently a hit and miss process-depending mostly on the natural immunodominance of the protein target…… due to the molecular decoys this leads to an large and inefficient discovery process with antibodies often being to the wrong an/or less functional epitopes. BMI’s Immune Refocusing Technology improves the efficiency by 10-100X and results in antibodies that are targeted to the most functional and broadest epitopes."
Biological Mimetics, Inc., 124 Byte Drive, Frederick, MD 21702
Phone: (301) 378-2551 || Fax: (240) 439-4975
Contact Us: please use our Contact Us Form
Copyright Biological Mimetics, Inc. All rights reserved.